Abstract
Unlabelled
The high glucose utilization of normal gray matter limits the detection of brain tumor tissue by PET using 18F-fluorodeoxyglucose (FDG). The aim of this study was to evaluate whether the examination of amino acid transport with the SPECT tracer 123l-alpha-methyl-L-tyrosine (IMT) allows better identification of tumor tissue than FDG-PET.Methods
Nineteen patients (16 with gliomas, 3 with nontumorous lesions) were included in the study. Two independent observers classified PET and SPECT images as positive or negative for tumor tissue and defined the extent of tumor with regions of interest. Tracer uptake of FDG and IMT was quantified by calculating the tumor uptake relative to contralateral gray and white matter.Results
SPECT studies were interpreted concordantly in 18 patients (kappa = 0.77) and all tumors were identified by both observers. PET studies were interpreted discordantly in 4 patients (kappa = 0.52) and only 10 tumors were identified by both observers, interobserver variability in definition of tumor extent was significantly lower in the IMT-SPECT than in the FDG-PET studies (p = 0.03). Mean tumor uptake relative to gray and white matter was 1.93 +/- 0.42 and 2.25 +/- 0.46 for IMT and 0.93 +/- 0.32 and 1.61 +/- 0.52 for FDG. All tumor uptake ratios were significantly (p < 0.01) higher for IMT than FDG, even when only glioblastomas were analyzed. No significant correlation was observed between the various uptake ratios of FDG and IMT.Conclusion
Despite the lower resolution and lower sensitivity of SPECT compared with PET, IMT-SPECT was clearly superior to FDG-PET in the detection and delineation of tumor tissue.Full text links
Free to read at jnm.snmjournals.org
http://jnm.snmjournals.org/cgi/content/abstract/38/5/802
Citations & impact
Impact metrics
Article citations
[11C]Methionine and [11C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis.
Mol Imaging, 19:1536012120968669, 01 Jan 2020
Cited by: 10 articles | PMID: 33147119 | PMCID: PMC7649862
Improved method for preparing Ni(II) complex of (S)-tyrosine Schiff base and its use in the automated synthesis of O-(2'-[18F]fluoroethyl)-l-tyrosine using solid-phase extraction purification.
Appl Radiat Isot, 127:122-129, 22 May 2017
Cited by: 1 article | PMID: 28570917
Modern brain tumor imaging.
Brain Tumor Res Treat, 3(1):8-23, 29 Apr 2015
Cited by: 81 articles | PMID: 25977902 | PMCID: PMC4426283
Review Free full text in Europe PMC
Radionuclides in drug development.
Drug Discov Today, 20(2):198-208, 07 Oct 2014
Cited by: 16 articles | PMID: 25304182
Review
[PET-MR in patients with glioblastoma multiforme].
Radiologe, 53(8):682-690, 01 Aug 2013
Cited by: 3 articles | PMID: 23949437
Go to all (33) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Eur J Nucl Med, 24(4):428-434, 01 Apr 1997
Cited by: 21 articles | PMID: 9096095
Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Eur J Nucl Med, 26(2):144-151, 01 Feb 1999
Cited by: 37 articles | PMID: 9933348
[Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Rofo, 176(8):1114-1121, 01 Aug 2004
Cited by: 20 articles | PMID: 15346287
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Semin Nucl Med, 33(2):148-162, 01 Apr 2003
Cited by: 95 articles | PMID: 12756647
Review